These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 21640664)
1. Pain and symptom assessment during multiple fractions of gynecologic high-dose-rate brachytherapy. Wiebe E; Surry K; Derrah L; Murray T; Hammond A; Yaremko B; D'Souza D Brachytherapy; 2011; 10(5):352-6. PubMed ID: 21640664 [TBL] [Abstract][Full Text] [Related]
2. The use of oral transmucosal fentanyl citrate during high-dose-rate gynecologic brachytherapy. Proud C Clin J Oncol Nurs; 2007 Aug; 11(4):561-7. PubMed ID: 17723969 [TBL] [Abstract][Full Text] [Related]
3. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542 [TBL] [Abstract][Full Text] [Related]
4. Patterns of pain and distress during high-dose-rate intracavity brachytherapy for cervical cancer. Kwekkeboom KL; Dendaas NR; Straub M; Bradley KA J Support Oncol; 2009; 7(3):108-14. PubMed ID: 19507459 [TBL] [Abstract][Full Text] [Related]
5. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days. Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878 [TBL] [Abstract][Full Text] [Related]
6. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
7. Posttraumatic stress disorder after high-dose-rate brachytherapy for cervical cancer with 2 fractions in 1 application under spinal/epidural anesthesia: incidence and risk factors. Kirchheiner K; Czajka-Pepl A; Ponocny-Seliger E; Scharbert G; Wetzel L; Nout RA; Sturdza A; Dimopoulos JC; Dörr W; Pötter R Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):260-7. PubMed ID: 24721589 [TBL] [Abstract][Full Text] [Related]
8. Performance characteristics and validation of the Opioid-Related Symptom Distress Scale for evaluation of analgesic side effects after orthopedic surgery. Yadeau JT; Liu SS; Rade MC; Marcello D; Liguori GA Anesth Analg; 2011 Aug; 113(2):369-77. PubMed ID: 21525182 [TBL] [Abstract][Full Text] [Related]
15. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data. Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683 [TBL] [Abstract][Full Text] [Related]
16. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain. Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582 [TBL] [Abstract][Full Text] [Related]
17. A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy. Viswanathan AN; Szymonifka J; Tempany-Afdhal CM; O'Farrell DA; Cormack RA Brachytherapy; 2013; 12(3):240-7. PubMed ID: 23415048 [TBL] [Abstract][Full Text] [Related]
18. Brachytherapy management of the retroverted uterus using ultrasound-guided implant applicator placement. Mayr NA; Montebello JF; Sorosky JI; Daugherty JS; Nguyen DL; Mardirossian G; Wang JZ; Edwards SM; Li W; Yuh WT Brachytherapy; 2005; 4(1):24-9. PubMed ID: 15737903 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]